AstraZeneca's Wainzua Recommended for EU Approval as New Therapy for Severe Asthma
The drug, Wainzua, specifically targets type 2 inflammation-driven asthma, a form associated with severe, persistent symptoms and significant impairment in quality of life.
Novartis Pays China’s Baiyu $70M Upfront, with $1.1B in Potential Milestones for Small Molecule Cancer Candidate
We discuss the significance of small molecule drugs in oncology, the rise of China’s biotech industry, and the potential market impact of this collaboration.
Roche's New Breast Cancer Drug Itovebi Receives FDA Approval
In a major development, the FDA has approved Roche’s new drug, Itovebi, which offers a promising option for patients with advanced HER2-positive breast cancer.
In a strategic move to strengthen its portfolio in the neurotechnology space, Stryker has acquired NICO Corporation, a specialist in minimally invasive brain surgery devices.
Vicebio Secures $100 Million to Develop Innovative Respiratory Virus Vaccines
The funding will fuel ongoing clinical trials of VXB-241, a bivalent vaccine targeting both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
Researchers Secure £3.9M Grant to Explore Early Axonal Dysfunction in ALS and FTD
Collaborative project involving researchers from King’s College London and University College London looks to develop therapeutic strategies for amyotrophic lateral sclerosis and frontotemporal dementia.
